Imidazolinones as nonpeptide angiotensin II receptor antagonists

[1]  G. Fur,et al.  Development of tetrazole bioisosteres in angiotensin II antagonists , 1994 .

[2]  W. Greenlee,et al.  Potent imidazole angiotensinII antagonists: acyl sulfonamides and acyl sulfamides as tetrazole replacements , 1994 .

[3]  J. Clément,et al.  A new series of imidazolones: highly specific and potent nonpeptide AT1 angiotensin II receptor antagonists. , 1993, Journal of medicinal chemistry.

[4]  J. Prost,et al.  Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. , 1992, Hypertension.

[5]  Peter Buhlmayer,et al.  Patent Update: Angiotensin-II Antagonists: Patent Activity since the Discovery of DuP-753 , 1992 .

[6]  J. Saavedra,et al.  Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing , 1992, Peptides.

[7]  P. Timmermans,et al.  The discovery of DuP 753, a potent, orally active nonpeptide angiotensin II receptor antagonist , 1992, Medicinal research reviews.

[8]  P. Timmermans,et al.  Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. , 1990, The Journal of pharmacology and experimental therapeutics.

[9]  P. Timmermans,et al.  Identification of angiotensin II receptor subtypes. , 1989, Biochemical and biophysical research communications.

[10]  P. Timmermans,et al.  Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307). , 1988, The Journal of pharmacology and experimental therapeutics.